Report Library
View More
Datamonitor Healthcare Oncology Dis...
September 29, 2023
Datamonitor Healthcare Infectious D...
September 29, 2023
Pulmonary Hypertension KOL Intervie...
September 27, 2023
Datamonitor Healthcare Oncology Dis...
September 27, 2023
Datamonitor Healthcare Oncology Dis...
September 27, 2023
Datamonitor Healthcare Oncology: Ut...
September 27, 2023
Datamonitor Healthcare Infectious D...
September 27, 2023
Pulmonary Hypertension KOL Intervie...
September 26, 2023
HR+/HER2- Breast Cancer KOL Intervi...
September 25, 2023
HR+/HER2- Breast Cancer KOL Intervi...
September 22, 2023
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 9/29/23 | AbbVie (ABBV) | Venclexta for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/27/23 | BrainStorm (BCLI) | NurOwn for Amyotrophic Lateral Sclerosis (ALS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/25/23 | BrainStorm (BCLI) | NurOwn for Amyotrophic Lateral Sclerosis (ALS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/23/23 | 4SC (VSC) | Resminostat for Cutaneous T-Cell Lymphoma (CTCL) - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/22/23 | Astellas Pharma (4503:JP) | Padcev for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 09/30/23 | Subscribers Only | Subscribers Only | Trial Announcement - Trial Completion |
| 09/30/23 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 09/30/23 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation (Emerging Markets) |
| 09/30/23 | Subscribers Only | Subscribers Only | Regulatory - IND/CTA Filing |
| 09/30/23 | Subscribers Only | Subscribers Only | Trial Announcement - Patient Enrollment Completed |
